NCT00835211View on ClinicalTrials.gov

Desmopressin Acetate 0.2 mg Tablets, Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Healthy
Interventions
DRUG

Desmopressin Acetate 0.2 mg Tablets

4 x 0.2 mg, single-dose fasting

DRUG

DDAVP® 0.2 mg Tablets

4 x 0.2 mg, single-dose fasting

Trial Locations (1)

H4R 2N6

MDS Pharma Sercives, Saint-Laurent

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835211 - Desmopressin Acetate 0.2 mg Tablets, Fasting | Biotech Hunter | Biotech Hunter